Login / Signup

Enantioselective formal [3+2]-cycloadditions to access spirooxindoles bearing four contiguous stereocenters through synergistic catalysis.

Jun-An XiaoJin-Lian LiXiu-Liang ChengKai ChenHai PengWen-Qiang ChenWei SuYan-Min HuangJun-An Xiao
Published in: Chemical communications (Cambridge, England) (2021)
An enantioselective ring-opening formal [3+2]-cycloaddition of spirovinylcyclopropyl oxindoles with enals via synergistic catalysis of palladium(0) and a chiral organocatalyst has been developed, affording spirooxindoles bearing four contiguous stereocenters in good yields with excellent enantioselectivities. The generality and utility of the protocol were also demonstrated through scale-up experiments and synthetic transformation of the resulting cycloadduct.
Keyphrases
  • cancer therapy
  • randomized controlled trial
  • reduced graphene oxide
  • drug delivery